首页 | 本学科首页   官方微博 | 高级检索  
检索        

还原型谷胱甘肽治疗全身炎症反应综合征研究
引用本文:关永东,邓素贞,雷间红,郭永军,陈洁文,江泽慧.还原型谷胱甘肽治疗全身炎症反应综合征研究[J].实用全科医学,2009,7(9):915-916.
作者姓名:关永东  邓素贞  雷间红  郭永军  陈洁文  江泽慧
作者单位:关永东,邓素贞,雷间红,郭永军,陈洁文(暨南大学第五附属医院急救中心,广东省清远市,511500);江泽慧(暨南大学医学院免疫研究所,511500) 
基金项目:广东省卫生厅医学科研基金 
摘    要:目的研究还原型谷胱甘肽(GSH)对治疗全身炎症反应综合征(SIRS)的临床疗效以及对炎性介质的影响,了解GSH对SIRS的治疗价值。方法选择符合SIRS诊断标准的48例患者,随机分为GSH治疗组(A组)和常规治疗组(B组)。观察两组患者的临床效果并检测治疗前后血清IL-6、TNF—Q、C-反应蛋白(CRP)、IL-10水平变化。结果治疗后A组患者临床症状改善较B组明显,MODS发生率下降,炎性介质CRP、IL-6、TNF-α、IL-10水平A组改变较B组明显改善。结论还原型谷胱甘肽能改善SIRS的临床症状,对炎性介质起免疫调理作用。

关 键 词:还原型谷胱甘肽  全身炎症反应  炎性介质

Clinical Study of the Therapeutic Value of the Reduced Glutathione in Systemic Inflammatory Response Syndrome (SIRS)
Institution:GUAN Yong-dong, DENG Su-zhen, LEI Jian-hong, et al. (First-aid Centre of Qingyuan People's Hospital, Qingyuan 511515, Guangdong, China)
Abstract:Objective To observe the therapeutic value of the reduced glutathione in critical illness cases with SIRS. Methods 48 SIRS patients were randomly divided into regular treatment group ( group B ) and reduced glutathione treatment group(group A). The efficacy of the therapy in both the groups were assessed and serum levels of C RP,TNF-α,IL-6 and IL-10 were measured on admission and the fifth day. Results SIRS markers all reduced more significantly in group A than in group B (P〈0.01 ). Serum CRP, TNF-α and IL-6 levels reduced more significantly in group A than in group B (P 〈 0. 01 ). Conclusion Reduced glutathione significantly improved the clinical effects of SIRS, prevented the MODS incidence.
Keywords:Reduced glutathione  Systemic inflammatory response syndrome  Inflammatory cytokines
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号